Sample size for FDA's in vitro population BE [Power / Sample Size]

posted by ElMaestro  – Denmark, 2017-09-08 19:24 (2853 d 12:49 ago) – Posting: # 17795
Views: 10,260

Hi all,

here's the pretty solution to a terrible challenge, originating from this guidance and which is now applied to about 40 different products.

It basically involves the application of an idea that is 40 years old and which was totally impractical at the time it was invented, and using it on FDA's pop BE approach. No-one has been able to deal with it analytically because the math gets too complicated (in fact, FDA's way to calculate the confidence limit for Eta is in itself an approximation).

:-):-)

A good weekend to all of you.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,425 posts in 4,928 threads, 1,676 registered users;
69 visitors (0 registered, 69 guests [including 10 identified bots]).
Forum time: 08:13 CEST (Europe/Vienna)

No problem can stand the assault of sustained thinking.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5